OBJECTIVE: On the luminal surface of injured arteries, platelet activation and leukocyte-platelet interactions are critical for the initiation and progression of arterial restenosis. The transcription factor nuclear factor-κB is a critical molecule in platelet activation. Here, we investigated the role of the platelet nuclear factor-κB pathway in forming arterial neointima after arterial injury. METHODS AND RESULTS: We performed carotid artery wire injuries in low-density lipoprotein receptor-deficient (LDLR(-/-)) mice with a platelet-specific deletion of IκB kinase-β (IKKβ) (IKKβ(fl/fl)/PF4(cre)/LDLR(-/-)) and in control mice (IKKβ(fl/fl)/LDLR(-/-)). The size of the arterial neointima was 61% larger in the IKKβ(fl/fl)/PF4(cre)/LDLR(-/-) mice compared with the littermate control IKKβ(fl/fl)/LDLR(-/-) mice. Compared with the control mice, the IKKβ(fl/fl)/PF4(cre)/LDLR(-/-) mice exhibited more leukocyte adhesion at the injured area. The extent of glycoprotein Ibα shedding after platelet activation was compromised in the IKKβ-deficient platelets. This effect was associated with a low level of the active form of A Disintegrin And Metalloproteinase 17, the key enzyme involved in mediating glycoprotein Ibα shedding in activated IKKβ-deficient platelets. CONCLUSIONS: Platelet IKKβ deficiency increases the formation of injury-induced arterial neointima formation. Thus, nuclear factor-κB-related inhibitors should be carefully evaluated for use in patients after an arterial intervention.
OBJECTIVE: On the luminal surface of injured arteries, platelet activation and leukocyte-platelet interactions are critical for the initiation and progression of arterial restenosis. The transcription factor nuclear factor-κB is a critical molecule in platelet activation. Here, we investigated the role of the platelet nuclear factor-κB pathway in forming arterial neointima after arterial injury. METHODS AND RESULTS: We performed carotid artery wire injuries in low-density lipoprotein receptor-deficient (LDLR(-/-)) mice with a platelet-specific deletion of IκB kinase-β (IKKβ) (IKKβ(fl/fl)/PF4(cre)/LDLR(-/-)) and in control mice (IKKβ(fl/fl)/LDLR(-/-)). The size of the arterial neointima was 61% larger in the IKKβ(fl/fl)/PF4(cre)/LDLR(-/-) mice compared with the littermate control IKKβ(fl/fl)/LDLR(-/-) mice. Compared with the control mice, the IKKβ(fl/fl)/PF4(cre)/LDLR(-/-) mice exhibited more leukocyte adhesion at the injured area. The extent of glycoprotein Ibα shedding after platelet activation was compromised in the IKKβ-deficient platelets. This effect was associated with a low level of the active form of A Disintegrin And Metalloproteinase 17, the key enzyme involved in mediating glycoprotein Ibα shedding in activated IKKβ-deficient platelets. CONCLUSIONS: Platelet IKKβ deficiency increases the formation of injury-induced arterial neointima formation. Thus, nuclear factor-κB-related inhibitors should be carefully evaluated for use in patients after an arterial intervention.
Authors: Li Zhu; Wolfgang Bergmeier; Jie Wu; Hong Jiang; Timothy J Stalker; Marcin Cieslak; Ran Fan; Laurence Boumsell; Atsushi Kumanogoh; Hitoshi Kikutani; Luca Tamagnone; Denisa D Wagner; Marcos E Milla; Lawrence F Brass Journal: Proc Natl Acad Sci U S A Date: 2007-01-23 Impact factor: 11.205
Authors: Colby Zaph; Amy E Troy; Betsy C Taylor; Lisa D Berman-Booty; Katherine J Guild; Yurong Du; Evan A Yost; Achim D Gruber; Michael J May; Florian R Greten; Lars Eckmann; Michael Karin; David Artis Journal: Nature Date: 2007-02-25 Impact factor: 49.962
Authors: Huan Wang; Weiyu Zhang; Rong Tang; Robert P Hebbel; M Anna Kowalska; Chunxiang Zhang; Jamey D Marth; Minoru Fukuda; Chuhong Zhu; Yuqing Huo Journal: Arterioscler Thromb Vasc Biol Date: 2009-04-16 Impact factor: 8.311
Authors: Zubair A Karim; Jinchao Zhang; Meenakshi Banerjee; Michael C Chicka; Rania Al Hawas; Tara R Hamilton; Paul A Roche; Sidney W Whiteheart Journal: Blood Date: 2013-04-23 Impact factor: 22.113
Authors: Zubair A Karim; Nicole R Hensch; Hanan Qasim; Fatima Z Alshbool; Fadi T Khasawneh Journal: Biochem Biophys Res Commun Date: 2018-04-14 Impact factor: 3.575
Authors: Marion Mussbacher; Manuel Salzmann; Christine Brostjan; Bastian Hoesel; Christian Schoergenhofer; Hannes Datler; Philipp Hohensinner; José Basílio; Peter Petzelbauer; Alice Assinger; Johannes A Schmid Journal: Front Immunol Date: 2019-02-04 Impact factor: 7.561
Authors: Sebastian Kruss; Luise Erpenbeck; Katharina Amschler; Tabea A Mundinger; Heike Boehm; Hans-Joachim Helms; Tim Friede; Robert K Andrews; Michael P Schön; Joachim P Spatz Journal: ACS Nano Date: 2013-10-04 Impact factor: 15.881
Authors: Katie L Lannan; Julie Sahler; Nina Kim; Sherry L Spinelli; Sanjay B Maggirwar; Olivier Garraud; Fabrice Cognasse; Neil Blumberg; Richard P Phipps Journal: Front Immunol Date: 2015-02-13 Impact factor: 7.561